The Journey From Bench To Patient: Accelerating FIH Trials To POC With Speed, Safety, And Certainty

Navigating the crucial transition from preclinical to clinical testing—specifically from First-in-Human (FIH) trials to Proof of Concept (POC)—is often one of the most challenging phases in drug development due to unknown risks, complex protocols, and regulatory hurdles. Success in this phase is accelerated by partnering with specialists who provide the necessary expertise, infrastructure, and agility for novel small molecules and biologics.

Key services essential for success include scientifically sound study design and protocol development, expert regulatory management, and comprehensive clinical conduct within dedicated Phase I units. These efforts are supported by robust recruitment strategies, flexible formulation and manufacturing, and integrated data sciences for seamless data flow from the clinic to the final report. The result is an accelerated pathway to early development milestones with greater speed, safety, and certainty.

Explore the comprehensive solutions designed to streamline your early clinical development.